Evogene (EVGN) Interest Coverage Ratio (2013 - 2026)
Evogene (EVGN) posted Interest Coverage Ratio of 0.81 for Q1 2026, down 94.55% sequentially from 14.89 in Q4 2025, and down 87.73% YoY from 6.61 in Q1 2025.
Evogene (EVGN) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
Evogene has reported Interest Coverage Ratio for 14 years, with the latest figure at 0.81 in Q1 2026.
- Quarterly Interest Coverage Ratio fell 87.73% year-over-year to 0.81 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.75 (down 39.28% YoY) and the FY2025 annual result came in at 7.26, up 229.65% from the prior year.
- Interest Coverage Ratio retreated to 0.81 in Q1 2026 per EVGN's latest filing, from 14.89 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 107.44 in Q4 2023 and troughed at 21.23 in Q2 2024.
- A 5-year average of 14.96 and a median of 7.39 in 2022 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2023: Interest Coverage Ratio tumbled 176.54% in 2022, then jumped 760.12% in 2023.
- Over 5 years, Interest Coverage Ratio stood at 19.8 in 2022, then surged by 642.58% to 107.44 in 2023, then plunged by 87.1% to 13.86 in 2024, then advanced by 7.41% to 14.89 in 2025, then sank by 94.55% to 0.81 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.81, 14.89, and 6.01 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Evogene | 4.38 Mn | 4.38 Mn | 204,000.00 | 0.81 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.81 |
| Dec 31, 2025 | 14.89 |
| Sep 30, 2025 | 6.01 |
| Jun 30, 2025 | -2.82 |
| Mar 31, 2025 | 6.61 |
| Dec 31, 2024 | 13.86 |
| Sep 30, 2024 | 2.05 |
| Jun 30, 2024 | -21.23 |
| Mar 31, 2024 | 24.61 |
| Dec 31, 2023 | 107.44 |
| Sep 30, 2023 | 38.38 |
| Jun 30, 2023 | 31.99 |
| Mar 31, 2023 | 12.63 |
| Dec 31, 2022 | -19.80 |
| Sep 30, 2022 | 27.83 |
| Jun 30, 2022 | 3.72 |
| Mar 31, 2022 | 7.39 |
| Dec 31, 2021 | 25.87 |
| Sep 30, 2021 | 53.81 |
| Jun 30, 2021 | 91.93 |